TORRENT PHARMACEUTICALS LTD. financial statements, including revenue, expenses, profit, and loss

The total revenue of TORNTPHARM for the last quarter is 27.32 B INR, and it's 2.71% higher compared to the previous quarter. The net income of Q3 23 is 4.43 B INR.